MYELOMA ALBERTA SUPPORT SOCIETY
WELCOME TO MYELOMA ALBERTA SUPPORT SOCIETY
We are a non-profit charitable organization formed and run by people living with myeloma and their supporters. Our purpose is to provide support to people living with myeloma, their caregivers, family and friends, as they deal with diagnosis and treatment.
We organize monthly meetings as well as educational events which provide fellowship, peer support, and information for all of us sharing a similar cancer experience.
UPCOMING MEETINGS
Our next Support Group meeting will be on Saturday April 13th, 2024 at Holy Spirit Lutheran Church at 11223 - 51 Avenue from 10:30 a.m. to 12:00 p.m.
MULTIPLE MILES FOR MYELOMA 2024
It is that time of year again when we start planning Multiple Miles for Myeloma. This year’s event is planned for Saturday July 20th, 2024. Once again it will be taking place at Hermitage Park.
Over the last 15 years we have raised over 1.5 million dollars. These efforts have gone directly to the University of Alberta Faculty of Medicine to be applied to myeloma research.
Please visit the following link to register: 2024 — Multiple Miles for Myeloma - 2024 - Edmonton — Race Roster — Registration, Marketing, Fundraising
Many Many thanks to our 2023 presenting sponsor NOVA Hotels, and to all our other sponsors including: Running Room DQ WCI EH! Royal Flush University of Alberta Western Moving and Storage Coronation Dental R and D Trailer Rentals
SIGN UP FOR NEWSLETTERS
Sign up to get our monthly newsletter, keeping you abreast of notice of our monthly meetings, and other events that we plan, important news pertaining to myeloma, and links to helpful information.
SIGN UP TO BECOME A MEMBER
Join us and become a member of MASS. Membership is $3 for 3 years per person, and all are welcome.
DONATE
We are a registered charity and all donations over $20 will receive a tax receipt. We use funds received to pay expenses of our Society, but the majority of funds received are forwarded to Myeloma Research at the University of Alberta and the Cross Cancer Institute.